Toripalimab Combined With Donafenib in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT04503902 · UNKNOWN
Trial details
- NCT number
- NCT04503902
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2023-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.